Doctor of Philosophy / Activation of a telomere maintenance mechanism is a vital step in the development of most cancers and provides a target for the selective killing of cancer cells. Cancers can use either telomerase or Alternative Lengthening of Telomeres (ALT) to maintain their telomeres and inhibition of either telomere maintenance mechanism can cause cancer cells to undergo senescence or apoptosis. Although telomerase inhibitors are undergoing clinical trials, on commencing this study very little was known about the role of ALT in cancer, what proteins were involved in its mechanism and regulation and how it could be targeted clinically. The primary aim of this thesis was to develop an assay for ALT suitable for examining archived tumour specimens and to begin using it to examine the prevalence and clinical significance of ALT in cancer. This assay and gene expression analysis was also used to identify genes that are involved in or associated with the activation of the ALT mechanism, to contribute towards the overall goal of an ALT cancer therapy. The ALT mechanism involves recombination mediated replication and ALT cells have a marked increase in a range of recombinational events specifically at their telomeres. Presumably, as a consequence of this the telomere lengths of ALT cells are very heterogeneous and on average long. This can be detected by terminal restriction fragment (TRF) Southern analysis, which has been used previously as the definitive test for ALT activity. However, TRF analysis requires intact genomic DNA and is unsuitable for tumour specimens which are commonly archived by paraffin embedding. Another hallmark of ALT is ALT-associated PML bodies (APBs) which are the subset of PML bodies that contain telomeric DNA. Work done in this study to consolidate APBs as a hallmark of ALT, combined with published data, showed 29/31 ALT[+], 3/31 telomerase[+] and 0/10 mortal cell lines/strains are APB[+]. The three APB[+]/telomerase[+] cell lines identified here had an order of magnitude lower frequency of APB[+] nuclei than the ALT[+] cell lines. APBs may be functionally linked to the ALT mechanism and contain the recombination proteins that are thought to be involved in the ALT mechanism. This study, in collaboration with Dr W-Q Jiang, strengthened this functional link by demonstrating that loss of ALT activity (as determined by TRF analysis) coincided with the disruption of APBs. The detection of APBs was developed into a robust assay for ALT in archived tumour specimens using a technique of combined immunofluorescence and telomere fluorescence in situ hybridisation. It was demonstrated that the APB assay concurred exactly with the standard assay for ALT (TRF analysis) in 60 tumours for which TRF analysis gave unequivocal results. The APB assay may be a more appropriate technique in the case of tumour specimen heterogeneity, which may explain why the APB assay was able to give definitive results when TRF analysis was equivocal. We demonstrated that intratumoral heterogeneity for ALT does exist and this could explain why about 3% of tumours in this study were APB[+] but with more than a ten-fold reduction in the frequency of APB[+] nuclei. This study also made the novel discovery of single stranded C-rich telomeric DNA inside APBs which potentially could be used to make the APB assay more suitable for routine pathology laboratory use. The APB assay was used to show that ALT is a significant concern for oncology. ALT was utilised in approximately one quarter of glioblastoma multiforme (GBM), one third of soft tissue sarcomas (STS) including three quarters of malignant fibrous histiocytomas (MFH), half of osteosarcomas and one tenth of non-small cell lung carcinomas (NSCLC). Furthermore, the patients with these ALT[+] tumours had poor survival; median survivals were 2 years for ALT[+] GBM, 4 years for ALT[+] STS including 3.5 years for ALT[+] MFH and 5 years for ALT[+] osteosarcoma. ALT[+] STS and osteosarcomas were also just as aggressive as their ALT[-] counterparts in terms of grade and patient outcome. ALT status was not found to be associated with response to chemotherapy in osteosarcomas or survival in STS. ALT was however, less prevalent in metastatic STS. The APB assay was a prognostic indicator for GBM and was correlated with three fold increased median survival in GBM (although this survival was still poor). ALT was more common in lower grade astrocytomas (88% ALT[+]) than GBM (24% ALT[+]) and ALT[+] GBM had an identical median age at diagnosis to that reported for secondary GBM. It is discussed that these data indicate that ALT was indirectly associated with secondary GBM and is possibly an early event in its progression from lower grade astrocytoma. This is relevant because secondary GBM have distinct genetic alterations that may facilitate activation of the ALT mechanism. Putative repressors of ALT could explain why this study found that ALT varied among the different STS subtypes. ALT was common in MFH (77%), leiomyosarcoma (62%) and liposarcoma (33%) but rare in rhabdomyosarcoma (6%) and synovial sarcoma (9%). ALT was not found in colorectal carcinoma (0/31) or thyroid papillary carcinoma (0/17) which have a high prevalence of telomerase activity and a reduced need for a telomere maintenance mechanism (low cell turnover), respectively. A yeast model of ALT predicts that one of the five human RecQ helicases may be required for ALT. Using the APB assay to test for the presence of ALT in tumours from patients with known mutations in either WRN or RECQL4 it was demonstrated that neither of these RecQ helicases is essential for ALT. Although p53 and mismatch repair (MMR) proteins have been suggested to be possible repressors of ALT, there was no apparent increase in the frequency of ALT in tumours from patients with a germline mutation in p53 codon 273 or in colorectal carcinomas that had microsatellite instability and thus MMR deficiency. Also contrary to being a repressor of ALT but consistent with its ability to interact with a protein involved in the ALT mechanism, the MMR protein MLH1, was demonstrated to be present in the APBs of an ALT[+] cell line. To further test for genes that may be involved in the ALT mechanism or associated with its activation, RNA microarray was used to compare the gene expression of 12 ALT[+] with 12 matched telomerase[+] cell lines; 240 genes were identified that were significantly differentially expressed (p<0.005) between the ALT[+] and telomerase[+] cell lines. Only DRG2 and SFNX4 were significantly differentially expressed after adjusting for the estimated false positive rate. Overall, DRG2, MGMT and SATB1 were identified as most likely to be relevant to the ALT[+] tumours and Western analysis indicated that DRG2 and MGMT levels were down-regulated after activation of ALT and up-regulated after activation of telomerase, whereas SATB1 protein levels appeared to be up-regulated after immortalisation but to a higher degree with activation of ALT compared to telomerase. Since lack of MGMT is known to be a determinant of temozolomide sensitivity in GBM, the possibility that ALT and the APB assay could be used to predict temozolomide sensitivity is discussed. The microarray data was consistent with MGMT expression being suppressed by EGF (p < 0.05), indicating that caution may be needed with combining EGFR inhibitors with temozolomide in ALT cancers. One ALT[+] cell line which did not express MGMT had TTAA sequence in its telomeres. This could possibly have resulted from mutations due to lack of MGMT expression and a possible role for MGMT in the ALT mechanism is discussed. Further analysis of the microarray data identified two groups of co-regulated genes (p < 5x10-5): CEBPA, TACC2, SFXN4, HNRPK and MGMT, and SIGIRR, LEF1, NSBP1 and SATB1. Two thirds of differentially expressed genes were down-regulated in ALT. Chromosomes 10 and 15 had a bias towards genes with lower expression in ALT while chromosomes 1, 4, 14 and X had a bias towards genes with higher expression levels in ALT. This work has developed a robust assay for ALT in tumour specimens which was then used to show the significance of ALT in sarcomas, astrocytomas and NSCLC. It has also identified genes that could possibly be molecular targets for the treatment of ALT[+] cancers.

Diss.--Philosophische Fakultät--Münster--Westfälische Wilhelms-Universität, 1991. / Bibliogr. p. 17-27.

Dans les cellules somatiques, les télomères s'érodent à chaque division cellulaire. Ce processus appelé « Sénescence Réplicative» est contrebalancé de manière basale chez la levure bourgeonnante S. cerevisiae par l'action de la télomérase qui, alors qu'elle est inactive dans les cellules somatiques des eucaryotes supérieures, est activée dans 85% des cancers. Un autre mécanisme impliqué dans les 15% des cas de cancer restants et est appelé Alternative Lengthening of Telomere (ALT). Dans ce processus, le maintien des télomères est assuré par des mécanismes de recombinaison télomérique induisant des échanges de séquences télomériques de chromatides sœurs (T-SCE).Nous avons évalué l'existence d'ALT dans la LLC-B connue pour rarement exprimer la télomérase. Nous avons montrer que 90% des patients LLC-B présentent une diminution de l'expression de TopoIIIα corrélée à une méthylation plus importante des îlots CpG de la région promotrice du gène suggérant que dans les LLC-B le maintien des télomères est défectueux.Nous avons étudié l'implication de la SUMOylation de TopoIIIα/Top3 dans les mécanismes de régulation du ALT. Nous avons montré que TopoIIIα était SUMOylée in vitro et in vivo au sein des cellules U2-OS ALT. Nous avons aussi observé chez S. cerevisiae que Top3 ne serait SUMOylée qu'en absence d'une activité télomérase. Nos résultats suggèrent que la SUMOylation de TopoIIIα augmenterait son activité in vitro et in vivo en diminuant son affinité pour les télomères une fois la recombinaison achevée et qu'elle serait requise pour son accumulation dans les APBs mais pas pour leur formation. / In somatic cells, telomeres erode with each cell division. This process named « Replicative Senescence » is basically counterbalanced in the budding yeast Saccharomyces cerevisiae by the action of telomerase which, while it is inactive in somatic cells of higher eukaryotes is activated in 85 % of cancer cases. Another process of telomere maintenance is involved in 15% of remaining cancer cases and is called Alternative Lengthening of Telomere (ALT). In this process, telomere maintenance is provided by telomeric recombination mechanisms inducing exchange of telomeric sister chromatid (T-SCE).We assessed the existence of an ALT mechanism in B-CLL known to rarely express telomerase. We have shown that 90% of B-CLL patients have a decreased expression of TopoIIIα correlated with largest methylation of CpG islands of the gene promoter region. Our results suggest that in B-CLL, telomere maintenance is defective either by telomerase or ALT mechanism.We investigated the involvement of post- SUMOylation of TopoIIIα/Top3 in mechanisms regulating ALT phenomenon. We have shown that TopoIIIα was SUMOylated in vitro and in vivo in U2-OS ALT cells. We also observed in S. cerevisiae that Top3p might be SUMOylated in absence of telomerase activity. Our results suggested that the SUMOylation of TopoIIIα increased its activity in vitro and in vivo by reducing its affinity for telomeres once recombination occurred and would be required for its accumulation in APBs but not for their formation.

Norint diagnozuoti kepenų funkcijos pažeidimus yra atliekami biocheminiai kraujo tyrimai. Net mažiausius paktimus kepenyse parodo kepenų fermentų padidėjimas, arba sumažėjimas kraujo serume. Mūsų tikslas buvo įvertinti 3 fermentų kitimo dinamiką (laktatdehydrogenazę (LDH), šarminę fosfatazę (ALPL) , aspartatamino transferazę (AST)) ganykliniu ir tvartiniu laikotarpiais. Rezultatai parodė, kad šarminės fosfatazės rodikliai buvo didžiausi tvartiniu laikotarpiu, o ganykliniame laikotarpyje ženkliai krito. Tačiau aspartatamino transferazės ir laktatdehydrogenazės aktyvumas svyravo nepriklausomai nuo laikotarpio. / In order to diagnose a hepatic disorder a biochemical blood test was carried out. Even slight changes in hepatic function show a decrease or an increase in the concentration of hepatic enzymes. Our aim was to monitor 3 enzymes: alkaline phosphatase (ALP), lactate dehydrogenase (LDH) and aminotransferase (AST). From the results of the blood test we deduced hepatic enzyme funcionality of local Lithuanian cow breed („ Lietuvos šėmųjų“). The experiment was carried out during indoor and pasture periods. The greatest activity of alkaline phosphatase was observed during the pasture period and during the indoor period its activity was greatly reduced. The activity of aminotransferase and lactate dehydrogenase was independent on the season.

In dieser Arbeit wurde überprüft, inwieweit sich verschiedene Lagerungsbedingungen von Zähnen auf die Verwertbarkeit von DNA im Zahninneren zur Gewinnung eines genetischen Fingerabdrucks auswirken. Die Untersuchungen an frisch extrahierten Zähnen ließen erkennen, dass die in dieser Arbeit verwendeten Methoden und DNA-Kits für die weitere Analyse der den unterschiedlichen Bedingungen ausgesetzten Zähne geeignet sind. Asensible Zähne weisen bereits bei der Zahnextraktion Zeichen von Degradation auf. Dagegen ist der kariöse Zerstörungsgrad an sich noch kein Ausschlusskriterium. Bei wurzelkanalbehandelten Zähnen konnten nur Systeme mit sehr kurzen Amplifikationsprodukten typisiert werden. Sie waren für eine genetische Identifizierung kaum geeignet. Bei der Analyse im Erdreich vergrabener Zähne nahm die Anzahl der typisierbaren Systeme nach einem Vierteljahr Liegezeit kontinuierlich ab, bis schließlich nach einem Jahr nur noch vereinzelt kleine Systeme detektiert werden konnten. Ein anderes Bild zeigte sich bei den in Wasser gelagerten Zähnen. Bis zu einem halben Jahr nach Versuchsbeginn konnte eine Typisierung aller Systeme durchgeführt werden. Erst nach einem Jahr war die Degradation so weit vorangeschritten, dass große Systeme keine Typisierung mehr erlaubten. Bei Zähnen, die der Sonnenstrahlung einen Monat ausgesetzt waren, war es dagegen problemlos möglich, einen vollständigen genetischen Fingerabdruck zu erfassen. Nach drei Monaten konnten allerdings nur noch vereinzelt sehr kleine Systeme gewonnen werden. Nach einem halben Jahr ergab lediglich der TPOX-vs eine erfolgreiche Typisierung. UV-Strahlung kann Zahnschmelz und –dentin durchdringen und DNA in recht kurzer Zeit degradieren. Die Zähne aus dem Sektionsgut des Instituts für Rechtsmedizin Würzburg lieferten unterschiedliche Ergebnisse, sodass hierzu keine generelle Aussage gemacht werden kann. Bei der Behandlung der Zähne mit Hitze von 200 °C konnte die DNA nur begrenzte Zeit vor Degradation geschützt werden. Bereits nach einer halben Stunde waren große Teile der Multiplex-Kits nicht mehr für eine Typisierung verwertbar. Das STR-System SE33 konnte allerdings noch ermittelt werden. Die Entnahmen zu späteren Zeitpunkten (60 min, 90 min und 120 min) lieferten fast nur noch einzelne STRSysteme. Eine knapp 30-jährige trockene Lagerung von Zähnen in einem Schrank mit Schutz vor Sonneneinstrahlung schadete der DNA-Analysierbarkeit kaum. Ein vollständiger Ausfall aller Systeme musste bei den Zahnproben von der Ausgrabung in Katzwang verzeichnet werden. Die Zähne dieser 380 bis 550 Jahre alten Schädel lieferten kein auswertbares DNA-Material mehr. Ebenso konnte mit diesen Untersuchungsmethoden aus den 2300 bis 2800 Jahre alten Zähnen aus der Dietersberghöhle kein analysierbares DNA-Material gewonnen werden. Es zeigte sich, dass Lagerbedingungen einen entscheidenden Einfluss auf die DNA-Qualität ausüben. Als DNA-schädigende Einflüsse können neben Mikroorganismen und Feuchtigkeit insbesondere UV-Strahlung und Hitze gelten. Der Faktor Zeit spielt bei günstigen Lagerbedingungen eine untergeordnete Rolle. / In this dissertation the possibility of winning a genetic fingerprint out of teeth that have been rested under different conditions was analysed. The examinations of recently extracted teeth showed that the methods and DNA-Kits used in this study are suitable for further analyses of teeth that have been exposed to different conditions. Asensible teeth already showed at time of extraction signs of degradation. However it was possible to get a genetic DNA-typing out of teeth which were destroyed by caries. Teeth with a root canal filling only showed systems with short amplification products. So they were not suitable for a genetic identification. The analysis of teeth which were buried in soil resulted that the number of detectable systems decreased continually after four month. After one year only a few systems were detected. The teeth which were stored in water gave a positive result in all systems after half a year. When the teeth have laid one year in water the degradation had gone so far that the big systems could not be typified anymore. Teeth that were exposed to sunshine for one month gave a complete detection of all analysed systems. Two month later only a few small systems were detected. After six months only the system TPOX-vs was successfully typed. UV-radiation gets through the dentin and the enamel and destroys the DNA very quickly. Two teeth out of the section good of the institute for forensic medicine showed completely different results. In one case the DNA-typing was successful, in the other one it wasn´t. Teeth that were treated in a 200 °C hot oven could protect the DNA for only a few minutes. After 30 minutes half of the analysed systems already were destroyed. After one hour and more only some sporadic systems were detected. The DNA-typing of a genetic fingerprint out of 30 years old teeth was successful. The complete failure of all systems showed examples of 380 to 550 years old teeth from a dig in Katzwang such as examples of 2.300 to 2.800 years old teeth out of the Dietersberg cave. For the DNA-quality it is very important to which conditions the teeth are exposed. DNA-damaging influences among other things are microorganisms, humidity, UV-radiation and heat. The factor time is not so important if the surrounding conditions are optimal.

Fanconi anaemia (FA) is an inherited disorder characterized by bone marrow failure, cancer predisposition and congenital abnormalities. The 12 known FA genes have been implicated in homologous recombination (HR), a process involved in telomere maintenance. A complex of at least 7 FA proteins promotes FANCD2 monoubiquitination and nuclear foci formation. FANCD2 colocalizes and interacts with HR proteins, however the role of FANCD2 in HR is unclear. Telomeres in dividing human somatic cells shorten until they reach a critical length, triggering most cells to undergo senescence or apoptosis. Rare immortal cells escape this crisis by expressing telomerase, or activating the Alternative Lengthening of Telomeres (ALT) pathway, which involves HR. FA core complex proteins and FANCD2 colocalize with telomeric foci in ALT, but not telomerase positive cells. Localization of FANCD2 to ALT telomeric foci requires monoubiquitination by the FA core complex, but is independent of ATM and ATR. FANCD2 primarily colocalizes with ALT telomeric DNA within ALT-associated PML bodies (APBs). Electron spectroscopic imaging and FISH experiments show that APBs contain extra-chromosomal telomeric repeat (ECTR) DNA that is non-nucleosomal. Depletion of FANCD2 causes marked increases in ECTR in ALT, but not telomerase positive cells. Overexpression of BLM, the helicase mutated in Bloom syndrome, also causes an ALT-specific increase in ECTR DNA. FANCD2 coimmunoprecipitates with BLM in ALT cells, and FANCD2 localization to ALT telomeric foci requires BLM expression. FANCD2-depleted ALT cells have reduced viability, signs of mitotic catastrophe, and multiple types of telomeric abnormalities, including increases in telomeric recombination, entanglements, colocalization with DNA repair proteins, and expression of fragile site characteristics. SiRNA depletion of FANCD2 does not cause overexpression of BLM, however codepletion of BLM with FANCD2 suppresses the telomere phenotypes caused by FANCD2 knockdown. Together this suggests that FANCD2 regulates BLM-dependent recombination and amplification of telomeric DNA within ALT cells.

Fanconi anaemia (FA) is an inherited disorder characterized by bone marrow failure, cancer predisposition and congenital abnormalities. The 12 known FA genes have been implicated in homologous recombination (HR), a process involved in telomere maintenance. A complex of at least 7 FA proteins promotes FANCD2 monoubiquitination and nuclear foci formation. FANCD2 colocalizes and interacts with HR proteins, however the role of FANCD2 in HR is unclear. Telomeres in dividing human somatic cells shorten until they reach a critical length, triggering most cells to undergo senescence or apoptosis. Rare immortal cells escape this crisis by expressing telomerase, or activating the Alternative Lengthening of Telomeres (ALT) pathway, which involves HR. FA core complex proteins and FANCD2 colocalize with telomeric foci in ALT, but not telomerase positive cells. Localization of FANCD2 to ALT telomeric foci requires monoubiquitination by the FA core complex, but is independent of ATM and ATR. FANCD2 primarily colocalizes with ALT telomeric DNA within ALT-associated PML bodies (APBs). Electron spectroscopic imaging and FISH experiments show that APBs contain extra-chromosomal telomeric repeat (ECTR) DNA that is non-nucleosomal. Depletion of FANCD2 causes marked increases in ECTR in ALT, but not telomerase positive cells. Overexpression of BLM, the helicase mutated in Bloom syndrome, also causes an ALT-specific increase in ECTR DNA. FANCD2 coimmunoprecipitates with BLM in ALT cells, and FANCD2 localization to ALT telomeric foci requires BLM expression. FANCD2-depleted ALT cells have reduced viability, signs of mitotic catastrophe, and multiple types of telomeric abnormalities, including increases in telomeric recombination, entanglements, colocalization with DNA repair proteins, and expression of fragile site characteristics. SiRNA depletion of FANCD2 does not cause overexpression of BLM, however codepletion of BLM with FANCD2 suppresses the telomere phenotypes caused by FANCD2 knockdown. Together this suggests that FANCD2 regulates BLM-dependent recombination and amplification of telomeric DNA within ALT cells.

Paracetamolio vartojimas yra viena iš dažniausių apsinuodijimo priežasčių daugelyje Europos šalių ir JAV. Šiose šalyse paracetamolio sukelti kepenų toksiniai pakenkimai sąlygoja nemažą hospitalizacijos ir mirčių atvejų skaičių. Apsinuodijimo paracetamoliu gydymas priklauso nuo nurytos paracetamolio dozės, laiko, praėjusio nuo nurijimo iki atvykimo į gydymo įstaigą, bei kitų veiksnių, padidinančių toksinio kepenų pakenkimo riziką. Vyrauja nuomonė, kad ūmaus apsinuodijimo paracetamoliu atveju paciento nurodyta nuryto paracetamolio dozė yra nepatikima informacija tolimesniam paciento gydymui ir priežiūrai. Mokslinių publikacijų, kuriose būtų patvirtinta apsinuodijusių pacientų nurodyta nurytos paracetamolio dozės svarba, taip pat yra palyginti nedaug. Paracetamolio sukeltų kraujo biocheminių rodiklių pokyčių tyrimai būtini, kad apsinuodiję pacientai būtų gydomi laiku ir tinkamai, bei komplikacijų prevencijai. Siekiant nustatyti paracetamolio sukelto kepenų pakenkimo laipsnį bei įvertinti prognozę, kraujo biocheminiai rodikliai turi būti tiriami kompleksiškai. Apsinuodijimo paracetamoliu dažnis Lietuvoje nėra žinomas, taip pat nežinomas ir paracetamolio sukelto toksinio kepenų pakenkimo dažnis. Šio darbo tikslas – nustatyti kraujo biocheminių rodiklių pokyčius apsinuodijus paracetamoliu. Rezultatai ir išvados. Ūmiai paracetamoliu apsinuodijusiems pacientams (paracetamolis nurytas per 24 val. laikotarpį) AST, ALT aktyvumo, bendro bilirubino koncentracijos, kraujo krešėjimo tyrimai... [toliau žr. visą tekstą] / Paracetamol is the most common cause of the poisoning in the USA and other European countries. In these countries paracetamol related liver injuries causes large number of cases of hospitalization and deaths. Treatment of paracetamol poisoning depends on ingested paracetamol dose, the time of admission to the hospital ant the other factors that increases risk of hepatotoxicity. A common perception is that patient-reported dosages are unreliable in the context of acute overdose. Only small number articles concerning the validity of patient reported dose are published. Investigation of the blood biochemical markers and investigation of their changes are important in order to treat the poisoning and prevent liver injuries. Prevalence of paracetamol poisoning is not known in Lithuania. Prevalence of liver injuries caused by paracetamol poisoning is not known as well. The aim of the study is to investigate the changes of blood biochemical markers in patients poisoned by paracetamol. The frequency of analyses of blood biochemical markers was analyzed; levels of blood biochemical markers were analyzed in the different time periods according to the admission to the hospital time and the time after paracetamol ingestion. Levels of blood biochemical markers were compared in the groups of self –poisoned patients and suicidal patients. Calculation of correlation coefficients between levels of blood biochemical markers and patient reported paracetamol dose was performed. In the group of... [to full text]

Opioids have been widely applied in clinics as one of the most potent pain relievers for centuries, but their abuse has deleterious physiological effects beyond addiction. We previously reported that opioids inhibit cell growth and trigger apoptosis in lymphocytes. However, the underlying mechanism by which microglia apoptosis in response to opioids is not yet known. In this study, we show that morphine induces microglia apoptosis and caspase-3 activation in an opioid-receptor dependent manner. Morphine decreased the levels of microglia phosphorylated Akt (p-Akt) and p-GSK-3β (glycogen synthase kinase-3 beta) in an opioid-receptor dependent manner. More interestingly, GSK-3β inhibitor SB216763 significantly increases morphine-induced apoptosis in both BV-2 microglia and mouse primary microglial cells. Moreover, co-treatment of microglia with SB216763 and morphine led to a significant synergistic effect on the level of phospho-p38 mitogen-activated protein kinase (MAPK). In addition, inhibition of p38 MAPK by its specific inhibitor SB203580 significantly inhibited morphine-induced apoptosis and caspase-3 activation. Taken together, our data clearly demonstrates that morphine-induced apoptosis in microglial cells, which is mediated via GSK-3β and p38 MAPK pathways.

This dissertation examines the potential existential roots of contemporary American social movements. I extract an existential social movement theory from Albert Camus’s philosophy that can elucidate surprising similarities and tactical differences across ongoing movements. I then apply the theory to Black Lives Matter and the Alt-Right which helps demonstrate that both movements express existential anxiety related to collective, racialized death. The social movement theory also clarifies the movements’ divergent political tactics as Black Lives Matter responds to existential anxiety by collectively acting to relieve immediate Black suffering and death which I argue is a Camusian rebellion. The Alt-Right conversely responds to existential anxiety by directing their energies towards achieving a teleological goal of racial homogeneity which I argue is a Camusian revolution. I use a variety of first-person sources including memoirs, interviews, and undercover exposés to support my thesis that Black Lives Matter and the Alt-Right are both responding to feelings of racialized existential anxiety, although they traverse disparate pathways.While the dissertation is primarily focused on racially motivated social movements, I argue that American environmental activists can learn from, and emulate Black Lives Matter’s tactics. Environmental activists argue that climate change is an existential crisis, and the anxiety of the death and devastation of climate catastrophe underlies much of today’s climate activism. Black Lives Matter has successfully transformed existential anxiety over state sanctioned Black death into meaningful and immediate reforms, without sacrificing its radical critiques of racial capitalism, mass incarceration, and white supremacy. I argue that environmental activists can likewise energize their existential anxieties into reforms that slow climate change, while continuing to challenge systemic degradation of the global environment. I conclude the dissertation by examining the 2020 Black Lives Matter activism in response to the deaths of Ahmaud Arbery, Breonna Taylor, and George Floyd. Ongoing and recent Black Lives Matter protests are rooted in the same collectively anxious response to Black death and have achieved even greater sociopolitical and cultural changes than the protests of years prior, providing further evidence for my thesis. / Political Science